BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 5, 2008
View Archived Issues
Benzofuran analogues inhibit amyloid-beta aggregation
Read More
Preclinical studies demonstrate PSN-119-2's potential as an antidiabetic with anorectic effects
Read More
First-in-man study supports bevacizumab-eluting stent development
Read More
Alexza's Staccato loxapine phase III trial in schizophrenic patients meets primary endpoint
Read More
SAR-114646 prevents ventricular fibrillation without prolonging ventricular repolarization in dogs
Read More
YSPSL safe in phase I/II study in renal transplant patients
Read More
Duloxetine shows promise in premenstrual dysphoric disorder in preliminary study / News in Context
Read More
Pharmaleads reports on dual NEL/APN inhibitor for pain
Read More
Integral Molecular initiates NIAID sponsored R&D program in influenza inhibitors
Read More
New treatment options for neurological disorders disclosed in recent patents
Read More
Pfizer and Medivation sign global agreement to codevelop and market Dimebon
Read More
Neurologix licenses XIAP gene for treatment of HD from Aegera
Read More
Opexa and MRF sign research collaboration in MS to support development of Tovaxin
Read More
Optimer completes enrollment in second phase III prulifloxacin trial
Read More
Acucela and Otsuka enter agreement for ACU-4429 in dry AMD
Read More
FDA grants fast track designation to Neurotech's NT-501 for retinitis pigmentosa and dry AMD
Read More
Pharmaxis enrolls patients in second pivotal phase III cystic fibrosis trial
Read More
Ablynx and Merck Serono to codiscover and codevelop Nanobodies
Read More
Antisoma commences phase II trial of AS-1411 in renal cell carcinoma
Read More
Recent patents describe new antidiabetic agents
Read More
Cytotopia starts enrollment in phase II CYT-997 study in glioblastoma multiforme
Read More
Novel therapeutic agents for obesity reported in recent Taisho patent
Read More
ImClone submits sBLA for Erbitux in first-line head and neck cancer
Read More
Phase III aclidinium studies show statistical significance in patients with COPD
Read More
Teva and Barr receive FTC request for additional acquisition information
Read More
Zentiva's Board continues to advise shareholders to reject sanofi takeover offer
Read More
Celator receives FDA orphan drug designation for anticancer agent CPX-351
Read More